stocktrader

US President Donald Trump announced deals with nine major pharmaceutical companies on Friday to lower US drug prices in exchange for three-year exemptions from threatened tariffs on pharmaceutical imports. The agreements bring the total number of drugmakers aligned with Trump’s pricing initiative to 14 of the 17 companies the administration targeted this year. The latest… Continue reading Trump secures deals with nine pharma firms to lower US drug prices, avert tariffs

XRP’s spot ETFs are sucking in roughly $50 million a day in fresh capital, hitting nearly $1 billion in inflows in under four weeks, the fastest adoption pace since Ethereum ETFs launched. Yet the token itself has cratered 11% over the past ten days and sits near $1.72, well below the $2.00 psychological support that… Continue reading XRP ETF inflows are rising even as token price falls: here’s why

US stocks, as represented by the benchmark S&P 500 index, are on track to close the year in green. But a so-called “Santa Claus rally” may not show up this year – and that doesn’t paint a particularly rosy picture of what’s to come in 2026, says Jonathan Krinsky, chief market technician at BTIG. The… Continue reading Don’t count on a ‘Santa Claus rally’ this year: market technician warns

Amazon has unified its artificial intelligence operations under one leader. The e-commerce and cloud computing giant appointed Peter DeSantis, a 27-year AWS veteran, to lead a newly unified organization spanning AI model development, custom chip design, and quantum computing research. The move represents a strategic reorganization aimed at accelerating Amazon’s push to compete directly with… Continue reading Amazon names new AI chief to take on OpenAI, Google & Microsoft

Famed investor Cathie Wood continues to see long-term potential in CoreWeave Inc. (NASDAQ: CRWV) even though the AI infrastructure firm has been cut in half over the past six months. The founder and chief executive of Ark Investment Management bought another 136,000 CRWV shares this week, split across two of her flagship exchange-traded funds (ETFs).… Continue reading Cathie Wood buys the dip in CoreWeave stock ‘again’: here’s why you shouldn’t

US stocks pulled back sharply at midday on Wednesday as investors dumped high-flying technology names and reassessed the AI trade’s underlying economics. The S&P 500 fell roughly 0.8%, the Nasdaq slumped about 1.3%, and the Dow dipped 0.3%. The selloff centered on two heavyweights, Oracle and Broadcom, both grappling with investor concerns about profitability and… Continue reading US midday market brief: S&P 500 falls 0.7% as tech stocks slide; Oracle, Broadcom lead declines

Lithium prices in China experienced a sharp increase on Wednesday following a significant regulatory action by the natural resource authority overseeing the country’s primary lithium-producing region.  The authority announced its decision to revoke 27 existing mining licences, according to a Reuters report.  This unexpected crackdown on a substantial number of operations immediately tightened the supply… Continue reading Supply fears push lithium futures to highest price since June 2024

For most of the past two decades, China’s economy could solve slow growth by pulling one of three levers. It could push investment, lift property, or sell more to the rest of the world. Today, one lever is broken, another is politically constrained, and the third is provoking resistance abroad. Though the economy is still… Continue reading Why China’s traditional growth model is breaking down

Medical-supplies distributor Medline has raised $6.26 billion in an initial public offering, claiming the title of the largest IPO of the year and securing a valuation of more than $50 billion. The US-based company, backed by private equity groups Blackstone, Carlyle and Hellman & Friedman, said on Tuesday it sold 216 million shares at $29… Continue reading Medline’s $6.3B IPO tops global listings in 2025 as US equity markets regain momentum